PRKN and lung adenocarcinoma: In addition, PRKN was markedly downregulated in lung adenocarcinoma (LUAD), colon adenocarcinoma (COAD), thyroid cancer (THCA), and lung squamous cell carcinoma (LUSC), respectively.